Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
CALL
Zillow
Z
$8.12B
| $665K | ﹤0.01% |
9,700
-11,900
| -55% | -$909K |
|
2102
PUT
Entegris
ENTG
$21.2B
| $665K | ﹤0.01% |
7,600
-1,200
| -14% | -$121K |
|
2103
CALL
Conagra Brands
CAG
$7.81B
| $661K | ﹤0.01% |
+24,800
| New | +$640K |
|
2104
PUT
BHP
BHP
$251B
| $660K | ﹤0.01% |
13,600
-600
| -4% | -$29.9K |
|
|
AIV
2105
Aimco
AIV
$375M
| $659K | ﹤0.01% |
74,847
+29,882
| +66% | +$265K |
|
|
2106
CALL
Entegris
ENTG
$21.2B
| $656K | ﹤0.01% |
+7,500
| New | +$757K |
|
2107
CALL
PENN Entertainment
PENN
$2.38B
| $652K | ﹤0.01% |
+40,000
| New | +$782K |
|
2108
CALL
Sarepta Therapeutics
SRPT
$2B
| $651K | ﹤0.01% |
+10,200
| New | +$1.07M |
|
2109
CALL
SharkNinja
SN
$25.9B
| $651K | ﹤0.01% |
7,800
+5,500
| +239% | +$560K |
|
2110
CALL
Kyndryl
KD
$2.84B
| $650K | ﹤0.01% |
20,700
+14,600
| +239% | +$547K |
|
2111
CALL
Zebra Technologies
ZBRA
$17.1B
| $650K | ﹤0.01% |
+2,300
| New | +$786K |
|
2112
CALL
Canadian Natural Resources
CNQ
$102B
| $650K | ﹤0.01% |
+21,100
| New | +$640K |
|
2113
CALL
Rocket Companies
RKT
$40.5B
| $648K | ﹤0.01% |
53,700
+10,100
| +23% | +$130K |
|
2114
CALL
Sable Offshore Corp
SOC
$904M
| $647K | ﹤0.01% |
+25,500
| New | +$653K |
|
2115
PUT
Transmedics
TMDX
$3.25B
| $646K | ﹤0.01% |
9,600
-2,500
| -21% | -$172K |
|
2116
iShares Core US Aggregate Bond ETF
AGG
$139B
| $645K | ﹤0.01% |
+6,521
| New | +$637K |
|
2117
CALL
Impinj
PI
$5.08B
| $644K | ﹤0.01% |
7,100
+2,100
| +42% | +$235K |
|
2118
State Street
STT
$53B
| $644K | ﹤0.01% |
+7,190
| New | +$687K |
|
2119
PUT
AeroVironment
AVAV
$7.49B
| $644K | ﹤0.01% |
5,400
+3,000
| +125% | +$461K |
|
2120
CALL
Pilgrim's Pride
PPC
$7.72B
| $643K | ﹤0.01% |
11,800
-21,600
| -65% | -$1.08M |
|
2121
Ardelyx
ARDX
$976M
| $642K | ﹤0.01% |
130,811
+4,281
| +3% | +$23K |
|
|
SCHW
2122
CALL
Charles Schwab
SCHW
$194B
| $642K | ﹤0.01% |
8,200
-10,100
| -55% | -$793K |
|
2123
FuboTV Inc
FUBO
$331M
| $640K | ﹤0.01% |
+18,278
| New | +$795K |
|
2124
E.W. Scripps
SSP
$305M
| $638K | ﹤0.01% |
215,501
+58,002
| +37% | +$127K |
|
2125
Celldex Therapeutics
CLDX
$3.24B
| $638K | ﹤0.01% |
35,141
+2,596
| +8% | +$58K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.